Mandate

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.

The recycling and waste business subject to the divestment comprises municipal and industrial waste management and recycling services for handling and recycling of plastics, metals, ash, slag and hazardous waste.  The businesses are located in Finland, Sweden, Denmark and Norway and currently employ approximately 900 employees. 

Vinge’s team mainly consisted of Peter Sundgren and Gustav Wahlberg (M&A), Johan Cederblad and Lina Österberg (Environmental), Martin Boström and Elis Allmark (Corporate Commercial), Sam Seddigh and Agnes Pigg (Employment), Linn Adelwald and Karl-Gustaw Tobola (Banking & Finance), Frida Ställborn (Real Estate) and Daniel Wendelsson, David Olander, Dagne Sabockis and Lovisa Lewin (Regulatory)

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026